Clinical Trial Update: Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials

View source ↗

Summary

This completed clinical trial surveys physicians to evaluate their knowledge of Exjade dosing and biological monitoring as described in the educational material…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload

Drugs mentioned

• Exjade (deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Iron Overload | Status: COMPLETED